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ABSTRACT
In vitro exposures to air pollutants could, in theory, facilitate a rapid and detailed assessment of molecular mechanisms of
toxicity. However, it is difficult to ensure that the dose of a gaseous pollutant to cells in tissue culture is similar to that of
the same cells during in vivo exposure of a living person. The goal of the present study was to compare the dose and effect
of O3 in airway cells of humans exposed in vivo to that of human cells exposed in vitro. Ten subjects breathed labeled O3
(18O3, 0.3 ppm, 2 h) while exercising intermittently. Bronchial brush biopsies and lung lavage fluids were collected 1 h post
exposure for in vivo data whereas in vitro data were obtained from primary cultures of human bronchial epithelial cells
exposed to 0.25–1.0 ppm 18O3 for 2 h. The O3 dose to the cells was defined as the level of 18O incorporation and the O3 effect
as the fold increase in expression of inflammatory marker genes (IL-8 and COX-2). Dose and effect in cells removed from in
vivo exposed subjects were lower than in cells exposed to the same 18O3 concentration in vitro suggesting upper airway O3
scrubbing in vivo. Cells collected by lavage as well as previous studies in monkeys show that cells deeper in the lung receive
a higher O3 dose than cells in the bronchus. We conclude that the methods used herein show promise for replicating and
comparing the in vivo dose and effect of O3 in an in vitro system.
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Recent proposals for identifying exposure hazards to toxic
agents involve the identification of “toxicity pathways” in pri-
mary cultures of human cells. The possibility of extrapolating
toxicity observed in vitro to human risk in vivo is attractive be-
cause it might allow a deeper understanding of the molecular
basis of injury through use of “omics” techniques as well as the
possibility of high throughput screening. Air pollutant gases and
aerosols present a unique challenge to in vitro work because of
difficulty replicating the dose and exposure conditions found in
vivo. Few studies have attempted to re-create in vitro the dose
and effect of an air pollutant observed in vivo. (National Research
Council, 2007).
The goal of the present study was to contribute a proof-of-
concept for direct extrapolation of air pollutant toxicity from in
Published by Oxford University Press on behalf of Toxicological Sciences 2014.
This work is written by (a) US Government employee(s) and is in the public domain in the US.
198
HATCH ET AL. 199
FIG. 1. Flow chart of the experimental design. The study involved both an in vivo
and an in vitro exposure to 18O3 of human epithelial cells. Bronchoalveolar lavage
cells and constituents were also measured for comparison with the epithelial
cells. Biological effects of O3 consisted of measurements of IL-8 and COX-2 gene
expression in cells harvested after exposure to unlabeled O3. Cells were sampled
1 h after in vivo exposures and immediately following the in vitro exposures.
vitro cell cultures to in vivo human bronchial epithelial cells. Ep-
ithelial cells were chosen because they secrete mediators which
initiate inflammatory events that are believed to be important
in human risk assessments. They also can be expanded in air-
liquid interface cultures and used in high throughput assays.
Ozone (O3) was chosen as a prototype pollutant because it
is one of the best-studied and ubiquitous of pure gaseous in-
halants (U. S. E. P. A., 2013).
We showed previously that exposure to heavy oxygen-
labeled ozone (18O3) results in incorporation of 18O into cells
and extracellular material obtained from bronchoalveolar lavage
fluid (BALF) of humans and animals (Hatch et al., 1994, 2013;
Plopper et al., 1998) creating a convenient micro-measurement
of O3 dose that is related to O3 toxicity. We have also demon-
strated that epithelial cells release mediators following O3 ex-
posure that are early markers of inflammation and that appear
to have health consequences in the human population (Devlin
et al., 1996; Devlin et al., 2012). The generation of these media-
tors can be quantified by gene expression assays. We here com-
pare the 18O3 dose and gene expression of two inflammatory me-
diators in cells obtained from human subjects exposed in vivo
with the same measurements made in human primary cells ex-
panded in culture and exposed in an air-liquid interface system
in vitro.
MATERIALS AND METHODS
A flow chart depicting the study design is shown in Figure 1. In
vivo exposures to 18O3 (for dose measurement) and unlabeled
O3 for gene expression measurement were compared with in
vitro exposures of the same length (2 h) that measured the same
dose and effect endpoints. In vitro exposures to 18O3 were per-
formed on cells expanded from two subjects, and gene expres-
sion changes were evaluated in cells expanded from three sub-
jects. Both the dose and effect in vitro studies employed the same
range of 18O3 or unlabeled O3 concentrations. Cells were har-
vested at the termination of exposure in both the in vivo and
in vitro studies.
In Vivo 18O3 Exposures of Human Subjects
For the dosimetry of ten subjects, eight (seven Caucasian and
one Hispanic) were male and two (one Caucasian and one His-
panic) were female, and the following data apply: age 26 ± 1
years (19–33 years), body weight 80.8 ± 2.8 kg, height 176.9 ±
3.0 cm, and resting forced vital capacity (FVC) 5.55 ± 0.27 l. For
the biological effects study of nine subjects, all were males (one
Black, one Hispanic and seven Caucasian), with the following
characteristics: age 23.7 ± 0.9 (20–29 years), body weight 86.1 ±
2.6 kg, height 182.0 ± 2.0 cm, and resting FVC 5.88 ± 0.2 l. The
study protocol was approved by the University of North Carolina
Committee on the Rights of Human Subjects (Institutional Re-
view Board) as well as the U.S. Environmental Protection Agency.
All individuals provided written informed consent and were re-
cruited under a contract to the Westat Corp. (Rockville, MD).
All subjects underwent a physical examination, with a com-
plete blood count and differential, serum electrolytes, glucose,
and liver enzymes. Female subjects had a negative urine preg-
nancy test. Volunteers were excluded from the study if they had
a smoking history within 2 years of the study, or were not able to
refrain from taking over-the-counter anti-inflammatory agents,
vitamins, or antioxidants for at least a week prior to exposure.
Participants who reported a recent respiratory tract infection (or
who had symptoms) were not studied for a period of at least 6
weeks after symptoms had disappeared.
Each volunteer was exposed on a single occasion for 2 h to
18O3. Subjects were seated on a bicycle ergometer with their fore-
head touching a pad on the top of a 6 inch diameter cone that
blew 18O3 downward across the face at a flow rate of 500 l/min.
The ozone concentration delivered did not deviate from the tar-
get concentration by more than ±5%. A sampling tube (with a
flow rate of 2–2.5 l/min) similar to a head-mounted microphone
collected breathing air 1–2 inches in front of the face of the sub-
ject. 18O3 concentrations were thus monitored in the breathing
zone every 10 s and stored as 2 min averages. Mean concentra-
tions in the breathing zone ranged from 0.21 to 0.33 ppm and
were 30–50% lower than in the incoming airstream.
Throughout the exposure, volunteers underwent moderate
intermittent exercise (15 min intervals) on the bicycle ergometer.
The level of exercise was targeted to a minute ventilation (Ve) of
25 l/min/m2 body surface area (∼50 l/min/subject). Prior to the
exposure day, all subjects participated in a training session to
establish the workload that would be required to achieve this Ve
and the same work load was targeted on the ergometer. Subjects
breathed naturally by mouth or nose depending on the subjects’
comfort level. On the study day, all subjects performed a pul-
monary function test prior to the exposure using a Sensormedics
Vmax 220 instrument and software (Sensormedics Corp., Yorba
Linda, CA) according to American Thoracic Society guidelines.
Spirometry was also conducted on all subjects immediately fol-
lowing the exposure. Decrements in FEV1 were 20% for all sub-
jects post- versus pre-exposure. All volunteers had forced expi-
ratory volume in 1 s (FEV1) and FVC baseline values of at least
80% of that predicted for their height, age, and gender. Subjects
were outfitted with a telemetry unit for the duration of the 18O3
exposure and bronchoscopy for continuous monitoring of heart
rate and rhythm as well as finger oxidimetry for O2 saturation.
Each subject was exposed twice, once to air and once to O3, sep-
arated by at least 2 weeks.
In vivo 18O3 and O3 generation. The 18O3 and unlabeled O3 ex-
posures were conducted identically in a chamber (dimensions
of 1.22 m wide × 2.44 m long × 1.83 m high) at the U.S. En-
vironmental Protection Agency Human Studies Facility on the
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campus of the University of North Carolina, Chapel Hill, NC. Air
from an oil-less compressor was passed through an air puri-
fier (ZEKS Nomonox model CDP480CD00, West Chester, PA). It
was then humidified by passage over heated deionized water.
18O3 was generated by passing a 1–2% stream of 18O2 (Isotec,
Inc., Miamisburg, OH; 99 atom %) in argon through a silent
electric discharge (model CMGK-F 0.5 O3 generator; Innovatec
Gerätetechnik GmbH, Rheinbach, Germany). The 18O3 concen-
tration was controlled by altering the flow of 18O2 into a constant
flow of argon that passed through the generator. Chamber rel-
ative humidity and temperature were measured once a second
and stored as 2 min averages that yielded an overall mean and
SD of 39.1 ± 0.2% and 22.5 ± 0.1◦C, respectively.
Exposures to unlabeled O3 were performed by metering pure
O2, along with dilution air, into a silent arc O3 generator. O3 con-
centration was controlled by varying the power to the generator,
but otherwise the exposures were done identically to the 18O3
exposures.
Bronchoscopic sample collection. A bronchoscopy was conducted
∼45 min following the completion of the 2 h exposure to 18O3
as described previously (Ghio et al., 1998) modified as follows.
Immediately prior to the procedure, subjects were given intra-
venous fluids through a saline lock catheter placed in an ante-
cubital vein to ensure they were hydrated. Primary bronchial ep-
ithelial cells were obtained by brush biopsy of both the right and
left mainstem bronchus. Each bronchus was brushed six times
in and out with a ∼5 cm excursion, and then repeated with a sec-
ond brush. The two cytology brushes from each side were kept
separate and the epithelial cells dislodged by agitation and brief
vortexing in 0.1 ml of cold Dulbecco’s phosphate buffered saline.
The dislodged cells were pelleted by centrifugation at 400 × g at
4◦C. For 18O measurements, the supernatant was removed and
the remaining cell pellet was lysed by pipetting up and down in
0.1 ml of 0.05% SDS. This solution was then diluted by adding an
additional 0.1 ml of water.
Bronchoalveolar lavage was conducted after the collection of
the brush biopsies. Three 50 ml aliquots of sterile saline were
sequentially injected into the right middle lung lobe. After each
aliquot of saline was instilled it was gently aspirated back into
the same syringe. The unfiltered lavage fluid was placed on ice
in 50 ml conical tubes. Mean percent recovery volumes (range)
of BALF from each lavage were as follows: wash no. 1; 29.4 ±
7.0% (14–38%), wash no. 2; 67.4 ± 9.2% (52–84%), wash no. 3;
77.8 ± 11.4% (58–92%). Samples were immediately centrifuged
at 1000 × g for 10 min at 4◦C to pellet the cell fraction. BALF
supernatants from all three aliquots were pooled and stored at
−80◦C for subsequent analysis of 18O/16O content. Cell pellets
from each aliquot were individually lysed by the addition of 0.1
ml of 0.05% SDS and the resulting cell lysates were dispersed by
pipetting up and down and then diluted with an equal volume
of water.
Primary Human Epithelial Cell Cultures and 18O3 Exposures
Cell collection and culture. Two dose-response in vitro18O3 expo-
sure experiments were performed to measure 18O and three to
measure mRNAs’ coding for pro-inflammatory mediators. Each
concentration had three technical replicates that were averaged.
Each experiment used cells originating from bronchial brush
biopsies from a separate volunteer that participated in the in
vivo exposure experiments. Three wells (technical replicas) were
exposed. Cells were expanded to passage three in bronchial ep-
ithelial growth medium (Lonza, San Diego, CA). This media con-
tained a background level of 0.83 mg/ml protein, 0.16nM retinoic
acid, and no ascorbic acid. Cells were plated on Costar Trans-
Clear filter supports with a 0.2m pore size (Costar Corp., Cam-
bridge, MA) and inserted into 12-well tissue culture plates (22.1
mm diameter wells; Corning Inc., Wilkes-Barre, PA). Each filter
support was pre-coated by addition of 0.2 ml of 40 ug/ml colla-
gen solution. Culture media under the interface (1 ml volume)
was enriched to 0.1uM retinoic acid after the cells reached 100%
confluence. Air-liquid interface culture conditions were initiated
24–48 h after the addition of retinoic acid by removing the apical
medium. The cells were maintained at air-liquid interface con-
ditions by replacing the basolateral medium (containing 0.1uM
retinoic acid) every 48 h for 4 days. The last medium exchange
was always done immediately prior to the 18O3 exposure. At this
stage of passage, cells were not yet producing a measurable mu-
cus layer on their surface.
In vitro 18O3 exposure of epithelial cells. Cells were exposed to four
18O3 concentrations and an air control (0.0, 0.25, 0.50, 0.75, or
1.0 ppm 18O3) for 2 h on the same day. No lid was present and
atmospheres consisted of filtered air or 18O3 in 5% CO2 and
maintained at 37◦C and 88% relative humidity. Previous studies
by us and others have shown that these concentrations do not
cause more than minimal (5% or less) decreases in cell viabil-
ity as measured with lactate dehydrogenase release assay. The
exposure chambers were 30 × 30 × 40 cm stainless steel boxes
with airflow passing from top to bottom through porous shelves.
They were housed inside Nuaire Incubators (Plymouth, MN) that
kept the temperature constant and provided the necessary CO2
analyzer. Air flowing through the chambers originated from an
oil-less compressor that was passed through a purifier (Aacdo
Medical Inc., Cleves, OH) and a humidifier (Pure Steam, Chaska,
MN) and pumped from the chamber using a Fox Venture Educ-
tor (Dover, NJ). 18O3 was generated similar to the in vivo expo-
sures except that the 18O3 generator was taken from a Bendix
NO/NOx analyzer (Lewisburg, WV). Chamber concentrations of
18O3 were monitored using TECO 49i O3 analyzers (Thermo Sci-
ence, Franklin, MA) and controlled by altering the flow rate of an
argon/18O2 mixture passing through the O3 generator.
In both in vivo and in vitro exposures, there was a small excess
(100–200 ppm) of 18O2 resulting from incomplete conversion of
18O2 to 18O3 (conversion efficiency is 1–2%). We have shown that
18O2 exposure at 21% results in 18O incorporation, but that 18O3
incorporation is 142,000- to 210,000-fold higher on a per ppm
basis (Supplementary table 1). This difference in incorporation
appears to be the result of higher chemical reactivity of the 18O3
and is evident even though the incorporation of 18O2 into cells
also includes uptake resulting from normal metabolic processes.
Tissue and BALF Fraction Preparation for 18O Analysis
BALF cell pellets were resuspended in 0.2 ml of 0.025% SDS. BALF
supernatants were combined and centrifuged for 1 h at 22,000 ×
g to obtain a white “surfactant pellet.” The resulting dried su-
pernatant contained proteins and lipids mixed in a high NaCl
matrix that could interfere with measurement of 18O. For this
reason, we precipitated the protein by adding trichloroacetic
acid (TCA) to a final concentration of 10% and centrifuged again
(40,000 × g for 1 h at 4◦C). The surfactant and TCA pellets were
resuspended in 0.4 ml of the 0.025% SDS solution.
Immediately following the in vitro exposures, cells were an-
alyzed for 18O content. This time point was chosen to minimize
metabolism of the 18O signal by cells and to coincide with the
same time point in which ozone-induced changes in mRNAs
coding for pro-inflammatory proteins have been observed. Cells
were lysed by the addition of 0.1 ml of 0.05% SDS to the api-
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cal surface. The cells were dislodged from the filter support us-
ing a pipette tip and the lysate transferred to a cryovial. The fil-
ter support was rinsed with an additional 0.1 ml of water and
this was pooled with the original 0.1 ml of cell lysate for a final
SDS concentration of 0.025% in the final sample. Epithelial cell
SDS lysates from both the in vivo and in vitro18O3 exposures and
BALF cells from the in vivo exposures were stored at −80◦C, then
lyophilized and stored with desiccant at 4◦C.
Analysis of 18O in lyophilized samples has been described
previously (Hatch et al., 1994; Santrock et al., 1989). Briefly,
lyophilized samples weighing 0.5–1.5 mg were placed into silver
cups (3 × 5 mm), crimped, and then placed into an elemental
analyzer (Carlo Erba Instruments, Italy) where all oxygen in the
samples was converted to CO under a stream of pure helium.
The elemental analyzer quantified the CO which yielded a per-
centage (per dry weight) of total elemental oxygen in each sam-
ple. The helium/CO effluent of the elemental analyzer was cap-
tured and passed by continuous flow through a heated (110◦C)
column of granular I2O5 (to convert CO to CO2), then a cryogenic
trap (−60◦C to remove produced I2), and then bled by capillary
into the vacuum of an isotope ratio mass spectrometer (SIRA 10,
VG instruments) where the ratios between CO2 masses were de-
termined. 18O3 exposed samples were compared with their nat-
ural abundance controls inserted into each run.
Quantitative RT-PCR for Detection of Gene Expression Changes
Gene expression changes of the inflammatory markers IL-8 and
COX-2 in human airway epithelial cells were quantified using
reverse transcription polymerase chain reaction (RT-PCR). To-
tal RNA was isolated using an RNeasy Mini Kit according to
manufacturer’s instructions (Qiagen, Valencia, CA). RNA quan-
tity was determined on a Nanodrop ND-1000 and RNA integrity
was assessed using RNA6000 Nano chips on a Bioanalyzer 2100
(Agilent). Total RNA (100–200 ng) was reverse transcribed to
generate cDNA using the High Capacity cDNA Reverse Tran-
scription kit (Life Technologies Applied Biosystems, Foster City,
CA). Quantitative fluorogenic amplification of cDNA was per-
formed using the ABI StepOnePlusTM Real-Time PCR System
(Applied Biosystems) with iTaq Universal Probes Supermix (Bio-
Rad), primer/probe sets for the target gene of interest multi-
plexed with b-actin (ACTB) primer/probe sets as the normal-
izing housekeeping gene (20× VIC/MGB, Primer Limited, Ap-
plied Biosystems). Values from triplicate technical replicates for
each sample were averaged and data analyzed using the DDCt
method to obtain fold change values following ozone exposure
with respect to air exposure values.
Data Analysis
The “incorporation of 18O” is defined here as the measure of O3
dose. A18O/16O ratio was derived from the relative CO2 masses
obtained from the mass spectrometer as a unitless “delta value.”
The enrichment in 18O in the 18O3 exposed samples was quanti-
fied and units changed to umoles of 18O/mole of total oxygen by
subtracting the mean of the background natural abundance of
18O from all samples. This background, consisting of ∼0.2 atom
% of all oxygen, was obtained from analysis of air-exposed cells
in the case of in vitro data or from blood plasma samples of the
subjects in the case of in vivo exposures. The denominator for the
enrichment in 18O was then converted to per gram dry weight
by use of the mean elemental percentage of oxygen (obtained as
output from the elemental analyzer). This value was obtained
from 10 subjects, each exposed to both clean air and ozone, and
paired t-tests were used to determine statistical significance (p
 0.05). For in vitro exposure experiments, one-way ANOVA was
used to calculate significance.
Analysis of gene expression performed on in vivo exposed
samples involved paired t-test with each subject serving as
his/her own control. Analysis of in vitro gene expression data




The cells obtained by brush biopsy were estimated to be greater
than 95% epithelial cells. We originally explored trying to de-
termine the percentage of different types of epithelial cells in
the biopsies but they come off the brush in clumps making
this impossible. The only cells that grow from these biopsies
are the basal cells. Ciliated cells, mucus cells, clara cells, etc.
are all terminally differentiated and do not divide in culture.
Cell counts and differentials obtained from BALF are shown in
Supplementary table 2. Percentage of polymorphonuclear leuko-
cytes (PMNs) was increased by O3 exposure at both the 1 h and
24 h BALF collection times.
We were able to obtain sufficient sample from a single culture
well of confluent epithelial cells, or from the brush biopsy from
one main bronchus. BALF cells and surfactant pellets yielded
larger samples than were obtained from TCA pellets of BALF. Our
18O analysis required 0.5–1.5 mg of dry weight with a total oxy-
gen percentage 10%. The bronchial biopsies barely met these
requirements and for this reason the gene expression changes
could not have been measured in the same samples as the 18O
dose. The detection limit for the 18O assay depends on (1) the
quantity of elemental oxygen in the sample (accuracy improves
with higher oxygen/sample) and (2) number of replicate samples
(accuracy improves with higher number of samples analyzed
due to both “memory” from the previous samples and increased
statistical power with larger sample numbers). Dry weights of
brush biopsy samples are shown in Supplementary table 3. The
18O values for the left and right bronchial brush biopsies were av-
eraged because there was no correlation between the two mea-
surements. The use of SDS for lysis and dispersion of samples
prevented sticking of dry sample to the walls of the tubes that
facilitated weighing the samples into silver sampling cups after
lyophilization. The contribution of SDS to the dry weight of the
samples was ∼10% for the BALF cell and surfactant fractions,
and 5% for the other samples.
Elemental Oxygen Percentages
Oxygen percentages that were used in converting the units of
18O dose as described above were as follows (mean ± SE): in vitro
epithelial cells expt. 1, 17.0 ± 0.7; in vitro epithelial cells expt.
2, 17.2 ± 1.2; in vivo bronchial brush biopsies, 12.7 ± 0.9; BALF
cells, 16.2 ± 1.1; BALF supernatant TCA pellet, 11.9 ± 0.8; BALF
surfactant pellet, 18.0 ± 0.2; plasma 1, 23.8 ± 1.7; Plasma 2, 21.4
± 1.1.
Comparison of In Vitro and In Vivo 18O3 Incorporation
18O3 exposure resulted in significant incorporation of 18O follow-
ing the in vivo study and each 18O3 concentration in the in vitro
study (Fig. 2). The mean ± SE 18O values of bronchial brush biop-
sies taken after in vivo18O3 exposure are plotted along with the
concentration response of 18O data from the in vitro exposure. In
vivo exposed cells showed lower 18O incorporation than in vitro
exposed cells at the same 18O3 concentration. For example, the
18O incorporation in vivo was 64% lower than that seen at the
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FIG. 2. In vitro and in vivo dose comparison: 18O incorporation into bronchial
brush biopsies collected from human subjects exposed for 2 h to 0.3 ppm 18O3
while exercising intermittently or human primary epithelial cells exposed in vitro
to a range of 18O3 concentrations (mean ± SE). Standard error bars are within the
data point for the in vivo data (N = 10 human subjects for in vivo data and 5 culture
wells derived from two replicate in vitro exposures to each 18O3 concentration
for in vitro data). Each mean shown is significantly elevated (* denotes p  0.05)
relative to natural background 18O (zero 18O3).
same 18O3 level (0.3 ppm) on the dose response curve of the in
vitro exposed cells. We were unable with the present sample size
to observe any relationships between 18O incorporation and sub-
ject age, sex, or race. Variability observed in the in vitro data could
have been the result of (1) differences between the subjects from
which cells were obtained, (2) variation in the two 18O analysis
runs, or (3) between the replicate culture wells exposed at each
18O3 concentration. The variability in natural abundance of 18O
(zero ppm 18O3) was small compared with variability among 18O3
exposed cells.
Comparison of In Vitro and In Vivo O3 Biological Effects
Figure 3 shows the fold increases (±SE) in gene expression of
IL-8 and COX-2 in bronchial brush biopsies from in vivo O3 expo-
sures and primary epithelial cell cultures exposed in vitro to the
same range of O3 concentrations as was used for the 18O3 study.
Similar to the 18O data, the in vivo gene expression was lower
than that observed following in vitro exposure. The IL-8 increase
in expression in the in vivo exposed cells fell about 30% below
that observed in vitro and the in vivo COX-2 response fell about
17% below the response observed in vitro. The in vitro expression
of IL-8 was higher than the expression of COX-2 but both genes
were induced in a concentration-related manner that leveled off
at 0.75 and 1.0 ppm O3. Although epithelial cells obtained from
subjects exposed in vivo showed elevations in gene expression
smaller than were observed at the lowest dose (0.25 ppm) used
in the in vitro study, the increases in both genes were significant
by paired t-test of the nine subjects studied.
Comparison of 18O in Bronchial Brush Biopsies to Three BALF Fractions
18O incorporation measured after in vivo exposure to 18O3 re-
sulted in higher 18O incorporation into cell and surfactant frac-
FIG. 3. In vitro and in vivo biological effects comparison of O3 exposures under
conditions similar to the dose comparison in Figure 2. Shown are the fold in-
creases in expression of IL-8 or COX-2 genes (means ± SE) in bronchial brush
biopsies obtained from nine human subjects exposed in vivo to O3 compared
with their response following exposure to clean air. Also shown are fold in-
creases of primary epithelial cells exposed in vitro to each O3 concentration
(means ± SE for three subjects and three replicates per subject) compared with
their response following exposure to clean air. Asterisks denote significance (p
 0.05).
FIG. 4. Comparison of 18O incorporation into epithelial cells (shown in Fig. 2) and
BALF constituents of the same subjects following exposure to 18O3 (0.3 ppm, 2
h with intermittent exercise). Means ± SE are shown for 10 subjects. All 18O3
exposed tissues had significantly elevated 18O when compared with the natural
abundance 18O concentration of blood plasma.
tions of BALF than bronchial brush biopsies from the same sub-
jects (Fig. 4). The BALF surfactant incorporated the highest lev-
els of 18O, which had a mean value slightly higher than the BALF
cells, fourfold higher than BALF TCA pellet, and about eightfold
higher than the mean of the left and right bronchial brush biop-
sies. A subject-by-subject plot of the relationship between the
four tissue pools is shown in Supplementary figure 1.
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Relationships Between Different In Vivo Sample 18O Measurements
No relationship was observed between the 18O incorporation in
the left and right bronchial biopsies. A search for relationships
across the 10 human subjects in the measured values for 18O in-
corporation in different tissue compartments yielded the result
that BALF surfactant 18O increased in proportion to BALF cell 18O
(R2 = 0.73; see Supplementary fig. 2) but not between other BALF
constituents (R2  0.5). The concentration of 18O3 measured at
the mouthpiece of the subjects (which ranged from 0.21 to 0.33
ppm) did not appear to be correlated with the 18O accumulation
in any of the individual tissue or BALF constituents or any com-
bination of the sum of the 18O concentrations in BALF.
DISCUSSION
We achieved a proof-of-concept for obtaining comparable mea-
surements of O3 dose and effect between in vivo exposed epithe-
lial cells and in vitro exposed primary epithelial cells exposed in
an air-liquid interface culture. Prior to this, few, if any, equiva-
lent measurements for an air pollutant gas had been identified
and compared under both in vivo and in vitro conditions. Prob-
lems have included finding equivalent denominators applicable
to both types of exposure. For example, measurements of re-
leased cytokines or LDH depend on equivalent volumes of ex-
tracellular fluid that cannot be controlled equally under in vivo
and in vitro conditions. Although the main goal of the study was
to compare the dose and response in epithelial cells, some valu-
able insights were obtained about the relative O3 dose in differ-
ent cell types. Epithelial cell production of inflammatory medi-
ators appears to be easily measured by gene expression assays,
and primary human epithelial cells appear to be a good model
that could be expanded in air-liquid interface cultures used in
high throughput assays.
This is the first report of 18O incorporation into human
bronchial epithelial cells in vivo or into any type of cell exposed
to 18O3 in vitro. Our previous studies examined BALF constituents
of humans and rats exposed in vivo to 18O3 but did not include
epithelial cells (Hatch et al., 1994). It was interesting that both
the O3 dose and effect observed in vivo always fell below that
observed in the in vitro exposures at the same air concentration
of O3. Previous studies that measured O3 air concentrations in
the posterior pharynx of exercising human subjects found that
fractional removal of O3 in the nose is ∼40% (Gerrity et al., 1994).
Thus, scrubbing of O3 in the upper airways might explain the
lower dose and effect of O3 in vivo compared with in vitro. Other
factors that could have influenced the relative dose and effect
between in vivo and in vitro exposures include the following. (1)
Brush biopsy of cells in vivo probably removed some underlying
cells that would have a lower exposure to O3 than the surface
cells, (2) there may have been differences in the competition of
the 18O3 reaction with antioxidants that do not form addition
products with 18O3 (see below), or (3) a longer (1 h vs. minutes)
delay following in vivo exposure compared with in vitro exposure
could have resulted in some clearance of 18O or a return to nor-
mal gene expression.
It is likely that the bronchial brush biopsy samples measured
here gave a low approximation of epithelial cell dose compared
with the distal airways that appear to be the main targets for
O3 in the human lung. A prior study of resting Rhesus mon-
keys showed that in vivo exposure (0.4 or 1.0 ppm 18O3 for 2
h) resulted in bronchial cell levels of 18O similar to those ob-
served here for bronchial cells of exercising humans (Plopper
et al., 1998): the bronchial cells of monkeys incorporated 4–7 ug
18O/g dry while the human bronchial cells incorporated ∼10 ug
18O/g dry. The smallest airways of the monkey (respiratory bron-
chioles) had a 2–4-fold higher 18O incorporation than cells of the
main bronchus suggesting that human terminal airways would
be higher as well. This higher dose deeper in the lung is sup-
ported by the 4–8-fold higher 18O incorporation observed here in
the BALF constituents. Histopathology data on O3 injury to ep-
ithelium and O3 dosimetry uptake models also predict the high-
est O3 dose and effect in the small terminal airways of all species
(Barry et al., 1985; Miller et al, 1978). It would not be possible to
biopsy tissues of these small airways in human subjects. The
above-mentioned references also demonstrate that although we
examined only one dose of 18O3 in the present in vivo study, a
dose response behavior should be expected. Taken together, our
results suggest that the dose response we observed here in the in
vitro exposed epithelial cells covered a reasonable range of doses
for human airway epithelial cells exposed in vivo.
In addition to the epithelial cell data, we learned that BALF
constituents experience a high dose of 18O3 compared with
bronchial epithelial cells. This difference might be due to the
larger surface area exposed or biochemical differences in reac-
tivity of the 18O3. We have observed in other studies that low
ascorbate is related to high 18O3 levels in BALF (Gunnison and
Hatch, 1999; Kari et al., 1997). The lack of ascorbate in the cul-
ture media used here would have resulted in a loss of ascorbate
from cells during culture (Lane et al., 2013) which would have in-
creased the incorporation of 18O3 in in vitro cells compared with
the cells exposed in vivo that are known to be bathed in extra-
cellular ascorbate (Slade et al., 1993; van der Vliet et al., 1999). In
an earlier study, we reported a 30–50% lower 18O incorporation
into human BALF cells and surfactant pellets than we observed
here. This was in spite of the fact that the earlier study involved
a higher 18O3 concentration (0.4 ppm, 2 h rather than 0.3 ppm,
2 h) and higher targeted minute ventilation (60 l/min/subject
vs. 50 l/min/subject in the present study). One reason for this
difference might be that the earlier study measured the 18O3
concentration at a site distant from the breathing zone of the
subjects so that surfaces for reaction with 18O3 within the ex-
posure chamber could have reduced the actual concentrations
inhaled. In the present study, 18O3 was measured in the breath-
ing zone to better ensure that losses of 18O3 on surfaces would
not occur. The in vitro exposures might also be affected by this
phenomenon, however, there appeared to be fewer surfaces for
reaction with 18O3 in the in vitro chambers than in the in vivo
chambers. Another finding is that our earlier study employed
dialysis of the BALF supernatant to separate the protein/lipid
fraction from the NaCl present in the saline lavage—a neces-
sity because high levels of NaCl can interfere with the 18O assay.
The earlier reported 18O levels in the dialyzed BALF high speed
supernatant were higher than the present results found in the
TCA-precipitated BALF high speed supernatant. It appears that
TCA treatment may have dissociated the 18O adduct, or failed
to concentrate the same extracellular materials in BALF as did
dialysis.
Limitations of the present study include the small number
of in vitro replicate exposures as well as of human subjects con-
tributing to the cultures. In addition, we observed significant
intra- and inter-subject variations in 18O in cells removed by
brush biopsy. Part of this variation may be attributable to the
fact that not all the inhaled ozone will react with the surface of
airway epithelial cells that are then removed by brush biopsy.
Some will react with compounds present in lung lining fluid
such as mucin or antioxidants and these compounds may differ
in concentration and among people or even in the same person
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on a day-to-day basis. This is also true to some extent within a
subject. It is not known if mucin or antioxidants are distributed
evenly throughout the airways. Another factor that may be con-
tributing to variability is that airway cells are not a monolayer
and there is a possibility that some of the cells not directly open-
ing into the airway and therefore not receiving a dose of ozone
(e.g., basal cells) would be removed during brush scraping to
varying degrees from one individual to another or even from
different locations within an individual. It is not known if the
makeup of cell composition (e.g., % of ciliated cells, mucin se-
creting cells, clara cells, basal cells, etc.) is homogenous through-
out the airway. Finally, some variability was probably due to the
limited mass of sample that made it impossible to obtain more
than one 18O analysis for each bronchus sampled. Although the
BALF cells sampled after in vivo exposure were obtained in a
higher sample mass than the tissue mass of bronchial brush
biopsies, we believe that the overall contribution of epithelial
cells to the inflammatory response would be greater because of
a larger surface area exposed to O3 and a higher secretion of in-
flammatory cytokines in epithelial cells than other cells (Devlin
et al., 1994). Future studies should compare the sensitivity to in-
jury of alveolar macrophages and epithelial cells and also deter-
mine the contribution of mucus or epithelial lining fluid cover-
ing the cells to the resulting dose and effect of O3. Another po-
tential limitation is the possibility that the subjects studied had
been exposed previously to ozone and as such might have ex-
perienced epigenetic effects that could alter the cell responses
following in vitro ozone exposure. No attempt was made to con-
trol for this possibility because there are so many other outside
influences that could also induce epigenetic effects, and because
we presently have no evidence for this type of change in the sce-
nario we have studied here.
In summary, our results suggest that in vitro exposure condi-
tions can be made to reasonably match the in vivo dose of O3 to
epithelial cells exposed in vivo and that comparable measures of
dose and effect can be obtained. These studies add confidence to
the possibility of extrapolating effects observed in vitro to effects
that might occur in human airways in vivo.
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